JENNA DAVISON, PA
Physician Assistant in FT WORTH, Texas. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
JENNA DAVISON, PA filed 1,785 Medicare Part D claims in 2023 as a Physician Assistant in FT WORTH, Texas, prescribing 48% generic.
- 2K
- Part D claims, 2023
- 48%
- generic prescribing
- $2.4K
- industry payments (Sunshine Act)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
JENNA DAVISON, PA's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023 — across all CMS prescribers nationally
1,785 Top 17% higher than 83% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
What does the federal data show about JENNA DAVISON, PA?
Quality data not reportedPrimary specialty
Medicare Part D claims
Specialty distribution in Texas
How Physician Assistant compares to other specialties among Texas providers
Physician Assistant share within Texas
Physician Assistant is one of the more visible NUCC categories in Texas
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Specialty board-certification context
Estimated specialty board-certified rate — Physician Assistant (ABMS / AOA reference)
- Est. board-certified rate
- 78%
- Physician Assistant ABMS/AOA estimate
Est. board-certified rate (Physician Assistant) — ABMS / AOA estimate
Verify credentials
- Verify via ABMS free public lookup
- Verify via AOA osteopathic boards
- Specialty volume Physician Assistant US NPIs
Specialty board-certified rate — Physician Assistant estimate
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus Maintenance of Certification cycles. CMS does not publish a per-provider board-certification field; the figure shown is the specialty-level estimated rate from ABMS / AOA reference data.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
JENNA DAVISON, PA appears in the CMS NPPES registry as a Physician Assistant provider holding PA credentials at 7801 OAKMONT BLVD, FT WORTH, TX, 76132, with a listed phone of (817) 263-0007. NPI 1417293960 was issued on 01/02/2013. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what DAVISON most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 1,785 prescription claims written by this provider, covering 268 Medicare beneficiaries and totaling roughly $762K in drug spend, split 52% brand-name and 48% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.
Physician Assistant is a high-volume specialty nationwide, with 149,975 enrolled providers across 56 states and an average of 790 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1417293960 |
|---|---|
| Specialty | Physician Assistant |
| Credentials | PA |
| Gender | Female |
| NPI Issued | 01/02/2013 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm JENNA DAVISON, PA's current license status, disciplinary history, and board certifications with the Texas Medical Board in Texas before relying on this page for a clinical or care decision.
How we sourced this profile
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for JENNA DAVISON, PA. Source: openpaymentsdata.cms.gov.
Total received
$2.4K
Largest payer
Lilly USA, LLC
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context — Texas TMB 2023 annual report
Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 — they are NOT specific to JENNA DAVISON, PA. To verify JENNA DAVISON, PA's current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Brand-heavy
52% brand-name claims vs 48% generic, on 1,785 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 3,965
- Total Day Supply
- 117,712
- Brand vs Generic
- 52% brand / 48% generic
- Brand Drug Cost
- $687K
- Generic Drug Cost
- $15K
Patient Demographics
- Average Patient Age
- 72.7 years
- Avg HCC Risk Score
- 1.58
- Gender Split
- 68% female / 32% male
- Age Distribution
- <65: 18, 65-74: 155, 75-84: 81, 85+: 14
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What JENNA DAVISON, PA prescribes most
Top Medicare Part D drugs by claim count, 2023
- Levothyroxine Sodium
Levothyroxine Sodium
280 claims
- Synthroid
Synthroid
218 claims
- Metformin Hcl 97
Metformin Hcl
97 claims
- Tresiba Flextouch … 61
Tresiba Flextouch U-100
61 claims
- Rosuvastatin Calcium 55
Rosuvastatin Calcium
55 claims
- Glimepiride 52
Glimepiride
52 claims
- Ozempic 52
Ozempic
52 claims
- Jardiance 43
Jardiance
43 claims
| Drug | Claims |
|---|---|
| Levothyroxine Sodium | 280 |
| Synthroid Levothyroxine Sodium | 218 |
| Metformin Hcl | 97 |
| Tresiba Flextouch U-100 Insulin Degludec | 61 |
| Rosuvastatin Calcium | 55 |
| Glimepiride | 52 |
| Ozempic Semaglutide | 52 |
| Jardiance Empagliflozin | 43 |
| Tirosint Levothyroxine Sodium | 36 |
| Trulicity Dulaglutide | 35 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Physician Assistant Overview
How JENNA DAVISON, PA fits within the Physician Assistant landscape nationally.
JENNA DAVISON, PA's 1,785 claims are above the specialty average of 790.
Nearby Physician Assistant Providers in Texas
Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as DAVISON.
Compare Physician Assistant nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Texas
Frequently Asked Questions
What is JENNA DAVISON, PA's specialty? ▼
How much does JENNA DAVISON, PA prescribe under Medicare Part D? ▼
Where is JENNA DAVISON, PA located? ▼
What is JENNA DAVISON, PA's NPI number? ▼
Does JENNA DAVISON, PA prescribe more brand-name or generic drugs? ▼
How many Physician Assistant providers are there in the US? ▼
What drugs does JENNA DAVISON, PA prescribe most often? ▼
Does JENNA DAVISON, PA accept Medicare? ▼
How can I verify JENNA DAVISON, PA's credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology